The links below are to publications on PubMed referring to PDBP: Parkinson's Disease Biomarkers Program. This list is gathered weekly from PubMed automatically.

Publication/References
Assessment of LIN28A variants in Parkinson's disease in large European cohorts.
Description: Diez-Fairen, Monica, et al. Assessment of LIN28A variants in Parkinson's disease in large European cohorts. ''Neurobiol Aging''. 2021 Apr; '''100''': 118.e1-118.e3
Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism.
Description: Wilkes, Bradley J, et al. Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. ''NPJ Parkinsons Dis''. 2023 Jun 5; '''9''' (1):85
Federated Learning for multi-omics: a performance evaluation in Parkinson's disease.
Description: Danek, Benjamin, et al. Federated Learning for multi-omics: a performance evaluation in Parkinson's disease. ''bioRxiv''. 2023 Oct 6;
Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA.
Description: De Francesco, Silvia, et al. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. ''Sci Rep''. 2023 Oct 13; '''13''' (1):17355
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease.
Description: Appleton, Ellen, et al. DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. ''Transl Neurodegener''. 2024 Jun 11; '''13''' (1):31
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.
Description: Yuan, Yuan, et al. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation. ''Mol Neurodegener''. 2024 Jun 11; '''19''' (1):47